Please assess the completion status of the following clinical trial:

Trial Title: Does Intravenous Cannabis Reduce Postoperative Nausea and Vomiting (PONV)?

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* ASA I-III~* elective open and laparoscopic surgery \>1hour~Exclusion Criteria:~* ambulatory surgery~* pregnancy, breast feeding~* \>ASA III~* BMI \>35~* antipsychotic, antiemetic, cytostatic therapy~* major cardiovascular, renal, hepatic, central nervous system disease~* current chronic cannabis consumption and hard drug abuse~* schizophrenia~* preoperative nausea and vomiting, vestibular disease~* not speaking german or french~* refusal to participate

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Receives 0.125mg/kg THC before emergence
- 2 (Type: PLACEBO_COMPARATOR): Receives NaCl before emergence

Based on this trial design, predict the completion outcome and termination type (if applicable).